您的购物车当前为空
G9a-IN-2 (Compound 7i) 是一种针对组蛋白甲基转移酶G9a的有效抑制剂,其IC50值仅为0.024 μM。该化合物能够有效降低H3K9me2水平,并能促进γ-球蛋白mRNA的表达,显示出对镰状细胞病 (SCD) 治疗的潜在效用。

G9a-IN-2 (Compound 7i) 是一种针对组蛋白甲基转移酶G9a的有效抑制剂,其IC50值仅为0.024 μM。该化合物能够有效降低H3K9me2水平,并能促进γ-球蛋白mRNA的表达,显示出对镰状细胞病 (SCD) 治疗的潜在效用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
G9a-IN-2 相关产品
| 产品描述 | G9a-IN-2 (Compound 7i) is an inhibitor of the histone methyltransferase G9a, with an IC50 of 0.024 μM. It can reduce the levels of H3K9me2 and induce the expression of γ-globin mRNA. G9a-IN-2 shows potential for improving Sickle Cell Disease (SCD). |
| 分子量 | 522.68 |
| 分子式 | C30H42N4O4 |
| CAS No. | 2648853-26-1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容